ADVERTISEMENT
The Pharmacology of Borderline Personality Disorder and Influential Studies
Mark Zimmerman, MD, professor of psychiatry and human behavior, Brown University, Providence, Rhode Island, discusses the key takeaways from Psych Congress 2021 his session titled "Not Too Much or Too Little: Facing the Challenges of Pharmacotherapy in Borderline Personality Disorder " (BPD) that explored the pharmacology of the disorder. He selects influential studies in the field and their impact on treatment.
In the upcoming part 3, Dr Zimmerman summarizes ways clinicians can take a "practical approach" when treating patients with BPD with medication.
In the previous part 1, Dr Zimmerman explored the key takeaways from his live 2021 Psych Congress session where he discussed the diagnoses and treatment of BPD.
Transcript coming soon.
